Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thaler

Showing results (51-60 of 292) with videos related to

Pageof 30
Sort By:
Biochemical Pharmacology|May 15, 1997
Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory proteinG Weiss, S Kastner, J Brock, et al.
Acta Haematologica|January 1, 1997
T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosineM Schirmer, W Hilbe, F Geisen, et al.
British Journal of Haematology|September 1, 1993
Diagnostic value of immunophenotyping in low-grade B-cell lymphomaW Eisterer, W Hilbe, C Ludescher, et al.
Blood Cancer Journal|July 26, 2012
Coexistence of primary myelofibrosis and chronic lymphocytic leukaemia: treatment of two different diseases with one agentS Burgstaller, S Wimmer, B Mayrbaeurl, et al.
Der Gynakologe|April 1, 1994
[Mucocele of the appendix. A rare differential diagnosis of right-sided adnexa tumor]C J Thaler, W Meier, A Billing, et al.
Lancet (London, England)|January 6, 2000
Screening for cervical neoplasia by self-assessment for human papillomavirus DNAP Hillemanns, R Kimmig, U Hüttemann, et al.
European Journal of Medical Research|August 4, 2001
S680N substitution of the follicle-stimulating hormone receptor is a common polymorphism not associated with spontaneous human twinningU Hasbargen, C J Thaler, H Ruebsamen, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trialM Schirmer, E Mur, K P Pfeiffer, et al.
Gynakologisch-Geburtshilfliche Rundschau|February 11, 2009
[Complications of hormonal contraception with estrogen and gestagens in the climacteric and in the postmenopausal period. 39th Congress of the "Zurich Discussion Group", October 2007]M Birkhäuser, W Braendle, H Kuhl, et al.
Lancet (London, England)|August 8, 1992
Secondary leukaemias after etoposideA G Zeimet, J Thaler, E Abfalter, et al.
Pageof 30

Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Biochemical Pharmacology|May 15, 1997
Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory proteinG Weiss, S Kastner, J Brock, et al.
Acta Haematologica|January 1, 1997
T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosineM Schirmer, W Hilbe, F Geisen, et al.
British Journal of Haematology|September 1, 1993
Diagnostic value of immunophenotyping in low-grade B-cell lymphomaW Eisterer, W Hilbe, C Ludescher, et al.
Blood Cancer Journal|July 26, 2012
Coexistence of primary myelofibrosis and chronic lymphocytic leukaemia: treatment of two different diseases with one agentS Burgstaller, S Wimmer, B Mayrbaeurl, et al.
Der Gynakologe|April 1, 1994
[Mucocele of the appendix. A rare differential diagnosis of right-sided adnexa tumor]C J Thaler, W Meier, A Billing, et al.
Lancet (London, England)|January 6, 2000
Screening for cervical neoplasia by self-assessment for human papillomavirus DNAP Hillemanns, R Kimmig, U Hüttemann, et al.
European Journal of Medical Research|August 4, 2001
S680N substitution of the follicle-stimulating hormone receptor is a common polymorphism not associated with spontaneous human twinningU Hasbargen, C J Thaler, H Ruebsamen, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trialM Schirmer, E Mur, K P Pfeiffer, et al.
Gynakologisch-Geburtshilfliche Rundschau|February 11, 2009
[Complications of hormonal contraception with estrogen and gestagens in the climacteric and in the postmenopausal period. 39th Congress of the "Zurich Discussion Group", October 2007]M Birkhäuser, W Braendle, H Kuhl, et al.
Lancet (London, England)|August 8, 1992
Secondary leukaemias after etoposideA G Zeimet, J Thaler, E Abfalter, et al.
Pageof 30